Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Over the Counter Drugs: Gaps and Potential Vulnerabilities in the Regulatory System

  Premium   Download PDF Now (8 pages)
Report Type Reports and Testimonies
Report Date April 28, 1992
Report No. T-PEMD-92-8
Subject
Summary:

While over-the-counter drugs are a common part of daily life, not all such drugs that reach the marketplace are safe or effective. GAO testified that (1) unlike prescription drugs, many over-the-counter drugs have not been proven safe or effective before being made publicly available; (2) the Food and Drug Administration (FDA) has statutory authority to inspect records and documents of prescription drug manufacturers, but not those of over-the-counter manufacturers; and (3) FDA collects less postmarketing surveillance information and conducts less product performance analysis for over-the-counter drugs than for prescription drugs.

« Return to search Government Accountability Office reports